Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [3]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN394880 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-S100 Calcium Binding Protein A7 (S100A7) (AA 1-102) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-102
- Isotype
- IgG
- Antibody clone number
- 1C1
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis.
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways.
Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.
Tieu DD, Peters AT, Carter RG, Suh L, Conley DB, Chandra R, Norton J, Grammer LC, Harris KE, Kato A, Kern RC, Schleimer RP
The Journal of allergy and clinical immunology 2010 Mar;125(3):667-75
The Journal of allergy and clinical immunology 2010 Mar;125(3):667-75
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G, Ovarian Cancer Association Consortium., Australian Ovarian Cancer Study Group., Australian Cancer Study (Ovarian Cancer).
PLoS genetics 2010 Jul 8;6(7):e1001016
PLoS genetics 2010 Jul 8;6(7):e1001016
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
West NR, Watson PH
Oncogene 2010 Apr 8;29(14):2083-92
Oncogene 2010 Apr 8;29(14):2083-92
Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways.
León R, Murray JI, Cragg G, Farnell B, West NR, Pace TC, Watson PH, Bohne C, Boulanger MJ, Hof F
Biochemistry 2009 Nov 10;48(44):10591-600
Biochemistry 2009 Nov 10;48(44):10591-600
Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.
West NR, Farnell B, Murray JI, Hof F, Watson PH, Boulanger MJ
Protein science : a publication of the Protein Society 2009 Dec;18(12):2615-23
Protein science : a publication of the Protein Society 2009 Dec;18(12):2615-23
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA